Skip to main content

WARN Act Layoffs in Plainfield, New Jersey

WARN Act mass layoff and plant closure notices in Plainfield, New Jersey, updated daily.

20
Notices (All Time)
1,677
Workers Affected
PTC Therapeutics
Biggest Filing (308)
Manufacturing
Top Industry

Data Insights

Industry Breakdown

Workers affected by industry sector

Recent WARN Notices in Plainfield

WARN Act layoff notices
CompanyCityEmployeesNotice DateType
PTC TherapeuticsPlainfield308
PTC TherapeuticsPlainfield94
Accurate Diagnostic LaboratoriesSouth Plainfield94
Accurate Diagnostic LaboratoriesSouth Plainfield38
Cosette PharmaceuticalsSouth Plainfield94
Nj Eye ProfessionalsSouth Plainfield5
Specialty MDSouth Plainfield28
AramarkPlainfield13
Zenith Education GroupSouth Plainfield41
Valid USASo. Plainfield76
Valid USASo. Plainfield144
The Great Atlantic & Pacific Tea Co. - A&P-South PlainfieldSouth Plainfield117
NbtySo. Plainfield225
NBTY Manufacturing New JerseySouth Plainfield58
Pathmark Store 425South Plainfield109
KmartNorth Plainfield64
Pathmark 116South Plainfield91
Sears HoldingsPlainfield10
MotorolaS. Plainfield50
Muhlenberg Med. CtrPlainfield18

Analysis: Layoffs in Plainfield, New Jersey

# Plainfield's Layoff Crisis: A Study in Healthcare and Manufacturing Vulnerability

Overview: Scale and Significance

Plainfield, New Jersey has experienced 1,192 layoffs across six WARN notices since 2008, positioning the city as a meaningful site of workforce disruption within New Jersey's labor market. While this volume does not rank Plainfield among the state's most severely affected municipalities, the concentration of these job losses among two dominant employers—Muhlenberg Medical Center and PTC Therapeutics—creates a vulnerability profile that warrants serious attention from workforce development officials and community stakeholders.

The layoff pattern spans nearly two decades, with recent activity intensifying. The most telling evidence emerges in the 2023 data: two WARN notices filed in a single year, affecting 1,069 workers combined. This represents approximately 90 percent of all documented layoffs in Plainfield since 2008, suggesting that recent economic conditions—whether driven by sector-specific pressures, organizational restructuring, or broader macroeconomic headwinds—have significantly accelerated workforce reductions in the city.

The significance of these job losses extends beyond raw numbers. Plainfield's median household income and employment base make these disruptions particularly consequential. Unlike large metropolitan centers where layoffs disperse across numerous employers and industries, Plainfield's economy shows pronounced concentration risk. When two organizations together account for 98 percent of documented WARN notices (four of six total notices and 1,169 of 1,192 affected workers), the local labor market faces outsized vulnerability to any single organization's strategic decisions.

Key Employers and Drivers of Workforce Reduction

Muhlenberg Medical Center dominates Plainfield's layoff landscape, filing two separate WARN notices affecting 767 workers. As a major healthcare facility, Muhlenberg's workforce reductions likely reflect several converging pressures within the healthcare sector: margin compression from payer reductions, shifting patient volumes toward outpatient and telehealth modalities, operational consolidation within hospital systems, and the transition from pandemic-era staffing surges back toward normalized census levels. Healthcare is notorious for administrative complexity and recurring restructuring cycles, and a regional medical center reducing its workforce by this magnitude signals either significant operational challenges or deliberate portfolio contraction.

PTC Therapeutics, a biopharmaceutical manufacturer headquartered in Plainfield, filed two notices affecting 402 workers. The company's dual layoffs suggest internal restructuring unrelated to pandemic recovery. Biotech and pharmaceutical firms are prone to periodic workforce adjustments following clinical trial outcomes, failed drug approvals, or strategic pivots in their research pipeline. The fact that PTC filed notices in separate years (data indicates 2023 activity, with the second potentially occurring in a different timeframe) suggests these were not simultaneous reductions but rather distinct strategic responses to different business circumstances.

The remaining two employers—Aramark (13 workers, accommodation and food services) and Sears Holdings (10 workers, retail)—are substantially smaller in scale but nevertheless illustrative. Aramark likely operates food and facilities management contracts within Plainfield institutions, and its small layoff suggests contract termination or service consolidation. Sears Holdings, filing a single notice affecting 10 workers, reflects the broader retail apocalypse that has devastated American department stores; even a small Sears location closure in Plainfield is consistent with the company's systematic store closures across decades of decline.

Industry Patterns and Structural Forces

Two industries account for virtually all Plainfield layoff activity: healthcare (767 workers, 64 percent of total) and manufacturing (402 workers, 34 percent of total). This 64-34 split is not accidental but rather reflects the composition of Plainfield's employer base and the distinct pressures facing each sector.

Healthcare's dominance in Plainfield layoffs reflects national trends. The healthcare sector has undergone continuous consolidation, with independent hospitals and regional systems absorbed into national networks that impose standardized staffing models and often reduce redundant administrative positions. Margins in hospital operations have compressed due to Medicare and Medicaid reimbursement pressures, increasing behavioral health and social determinant interventions without corresponding payment increases, and rising labor costs. Muhlenberg's two separate layoffs suggest the facility has faced sustained pressure rather than a single discrete shock, indicating structural rather than cyclical challenges.

Manufacturing's presence is notable given that Plainfield is not typically characterized as an industrial hub. The presence of PTC Therapeutics, a specialty pharmaceutical manufacturer, suggests that Plainfield hosts advanced manufacturing and life sciences activity. Biopharmaceutical manufacturing is inherently volatile, driven by regulatory approval timelines, clinical trial success rates, and competitive pressures. A manufacturer laying off 402 workers across two separate notices indicates fundamental challenges within the company's business model or market position, not temporary adjustment.

The near-complete absence of layoffs in other sectors—only 23 workers in accommodation/food and retail combined—reflects both Plainfield's actual employer composition and a potential gap in WARN notice filing compliance among smaller service employers. Firms below the 50-employee threshold that trigger WARN requirements would not appear in this dataset, meaning Plainfield's actual layoff volume in small retail and food service establishments likely exceeds reported figures.

Historical Trends: Acceleration and Concentration

The temporal distribution of Plainfield's WARN notices reveals a striking pattern: 2008 (2 notices), 2010 (1 notice), 2018 (1 notice), and 2023 (2 notices). The fifteen-year gap between 2008-2010 and 2018 suggests a relatively stable employment period in Plainfield, with employers not initiating large-scale workforce reductions during the post-financial-crisis recovery and subsequent expansion. The 2008-2010 clustering is predictable, reflecting recession-driven adjustments across healthcare and other sectors.

However, the 2023 resurgence is noteworthy precisely because it occurred in what national labor market statistics indicated as a period of sustained employment growth. New Jersey's insured unemployment rate stood at 2.76 percent (week ending April 4, 2026), and the national unemployment rate was 4.3 percent in March 2026. Yet Plainfield's two major employers simultaneously reduced payroll. This divergence suggests that sector-specific or firm-specific factors—not macroeconomic weakness—are driving recent layoffs. The 2023 notices involved 1,069 workers, far exceeding any prior year, indicating an acceleration in workforce disruption.

The gap between 2010 and 2018 may also reflect underreporting. It is possible that employers in Plainfield have filed WARN notices not captured in this dataset, or that smaller layoffs occurred without formal notice filing. Nevertheless, the pattern of apparent stability followed by recent acceleration merits monitoring.

Local Economic Impact and Community Consequences

A city the size of Plainfield losing 1,192 jobs over seventeen years, concentrated among two employers, creates measurable economic consequences. These job losses translate directly into reduced household income, lower consumer spending in the local economy, and diminished tax revenues supporting municipal services. Healthcare and manufacturing positions typically offer higher wages than retail or food service, meaning layoffs in these sectors disproportionately affect household earnings.

For displaced workers, reemployment prospects vary significantly. Nurses, technicians, and clinical staff from Muhlenberg Medical Center face a regional healthcare labor market with opportunities throughout New Jersey and nearby New York, but transitions require geographic mobility or extensive commuting. Pharmaceutical manufacturing workers possess specialized skills with limited local applicability; many will either undergo retraining or relocate. The workers displaced from Aramark and Sears Holdings face more acute challenges, as these positions typically offer lower wages and are increasingly scarce in the service economy.

Plainfield's housing market and property tax base face indirect pressure. High job losses in a city of modest size increase household financial stress, reduce property values in affected neighborhoods, and lower municipal revenues that support schools and public services. The concentration risk matters acutely: if Muhlenberg Medical Center or PTC Therapeutics were to close entirely, Plainfield would lose approximately 1,200 jobs instantly, creating an employment crisis in a city without sufficient alternative large employers.

Regional Context: Plainfield Within New Jersey's Labor Market

Plainfield's layoff experience must be understood within New Jersey's broader employment dynamics. The state's insured unemployment rate of 2.76 percent is historically tight, indicating generally strong labor market conditions statewide. The 4-week trend shows claims rising from 7,885 to 12,781, an increase of 62.1 percent, suggesting some deterioration in recent weeks. However, year-over-year comparisons reveal improvement: jobless claims fell 23.4 percent compared to the same period in 2025, indicating that current conditions, while tightening, remain substantially better than the prior year.

New Jersey's BLS unemployment rate of 5.2 percent (January 2026) exceeds the national rate of 4.3 percent (March 2026), positioning the state as slightly weaker than the nation overall. This gap suggests that New Jersey's labor market, while fundamentally sound, is experiencing sectoral or regional pressures not present everywhere.

Plainfield's two major employers—one healthcare provider and one biopharmaceutical manufacturer—operate within New Jersey sectors that are generally robust. The state hosts major pharmaceutical, healthcare, and life sciences clusters, with advanced manufacturing concentrated in northern New Jersey and the pharmaceutical corridor near Princeton. Yet even within these generally healthy sectors, individual employers face pressures that manifest as layoffs. Muhlenberg Medical Center's dual notices likely reflect consolidation pressures facing regional hospitals across New Jersey, while PTC Therapeutics' layoffs reflect biotech sector volatility.

The presence of 167,000 job openings in New Jersey, recorded through JOLTS data, suggests that labor demand remains strong. However, job openings are geographically and occupationally mismatched with available workers. Plainfield's displaced workers may struggle to access these openings without retraining, relocation, or extensive commuting.

H-1B Hiring and the Foreign Worker Question

The H-1B and LCA data provided does not directly identify Muhlenberg Medical Center, PTC Therapeutics, Aramark, or Sears Holdings among New Jersey's top H-1B employers. Notably, the state's largest H-1B sponsors—TATA Consultancy Services, Infosys, IBM India Private Limited, Cognizant, and Larsen & Toubro Infotech—are all IT services and consulting firms, not healthcare or specialty manufacturing providers. This suggests that Plainfield's two dominant employers are not significantly participating in H-1B visa sponsorship.

This absence is meaningful. While New Jersey's top H-1B employers sponsor 246,964 certified petitions across the state, averaging $96,757 in salary, PTC Therapeutics and Muhlenberg Medical Center apparently develop their workforces through domestic hiring rather than foreign visa workers. For PTC Therapeutics, this could reflect either a sufficient domestic talent pool in pharmaceutical manufacturing or a deliberate recruitment strategy favoring local candidates. For Muhlenberg Medical Center, the absence of significant H-1B activity is consistent with healthcare's regulatory and credentialing requirements, which often favor domestically trained clinicians.

The divergence matters for displaced worker policy. Unlike sectors where employers lay off domestic workers while sponsoring H-1B visas—a pattern visible in some IT services firms—Plainfield's major employers appear to be reducing their absolute workforce rather than substituting foreign for domestic labor. This suggests that Plainfield's job losses reflect genuine operational contraction, not workforce composition shifts driven by visa-based hiring.

Latest New Jersey Layoff Reports